Yoriko Yamashita
Yoriko Yamashita publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders and Occupational and environmental lung diseases.
- World rank
- #3,807,836 of 7,710,434 ranked researchers
- Rank in Japan
- #98,591 of 383,136
- Works
- 113
- Citations
- 3k
- Citations per work
- 26.7
What does Yoriko Yamashita research?
Yoriko Yamashita's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4842.5%
- Health Sciences4741.5%
- Medicine4741.5%
- Life Sciences1816.0%
- 1Oncology13% of their works
- 2Pulmonary and Respiratory Medicine11% of their works
- 3Molecular Biology11% of their works
- 4Pathology and Forensic Medicine9% of their works
- 5Surgery9% of their works
- 6Immunology5% of their works
Research topics
- Lymphoma Diagnosis and Treatment
- Viral-associated cancers and disorders
- Occupational and environmental lung diseases
- CNS Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Ovarian cancer diagnosis and treatment
- Immune Cell Function and Interaction
- Cutaneous lymphoproliferative disorders research
Which keywords describe Yoriko Yamashita's research?
The keywords of their largest research topics: Rituximab, Classification, Lymphoma, Epstein-Barr Virus, Kaposi's Sarcoma, Chemotherapy, Prognostic Factors and BAP1 mutations.
- NK Cell Recognition
- Cutaneous Lymphomas
- Genomic Analysis
- Chronic Lymphocytic Leukemia
- Primary CNS Lymphoma
- BAP1 mutations
- Chemotherapy
- Epstein-Barr Virus
- Classification
- Rituximab
- Lymphoma
- Kaposi's Sarcoma
- Prognostic Factors
- Malignant Pleural Mesothelioma
- Prognostic Scoring System
- Genomic Aberrations
- Ovarian Cancer
- Mycosis Fungoides
- Natural Killer Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Rituximab312 topics
- Classification241 topic
- Lymphoma241 topic
- Epstein-Barr Virus171 topic
- Kaposi's Sarcoma171 topic
- Chemotherapy152 topics
- Prognostic Factors122 topics
- BAP1 mutations101 topic
- Malignant Pleural Mesothelioma101 topic
- Primary CNS Lymphoma81 topic
- Prognostic Scoring System81 topic
- Chronic Lymphocytic Leukemia71 topic
- Genomic Aberrations71 topic
- Genomic Analysis71 topic
- Ovarian Cancer71 topic
- Cutaneous Lymphomas51 topic
- Mycosis Fungoides51 topic
- NK Cell Recognition51 topic
- Natural Killer Cells51 topic
Where does Yoriko Yamashita work?
Yoriko Yamashita's main affiliation in the publication record is Nagoya University, Japan.
How many publications and citations does Yoriko Yamashita have?
OpenAlex counts 113 works and 3,022 citations for Yoriko Yamashita, an h-index of 29, ranking #3,807,836 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yoriko Yamashita. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.